| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.3M | -49.6% |
| Cost of Revenue | $5.7M | -58.3% |
| Gross Profit | $6.6M | -38.4% |
| R&D Expense | $4.2M | +10.0% |
| SG&A Expense | $15.1M | -19.2% |
| Operating Income | -$26.9M | +24.5% |
| Pre-tax Income | -$15.9M | +70.7% |
| Income Tax | $13K | +85.7% |
| Net Income | $53.4M | +198.9% |
| EPS (Basic) | $1.29 | +169.4% |
| EPS (Diluted) | $0.87 | +146.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $36.4M | +174.6% |
| Accounts Receivable | $1.7M | -23.8% |
| Inventory | $2.6M | -33.1% |
| Current Assets | $55.8M | +113.3% |
| Total Assets | $62.4M | +72.6% |
| Current Liabilities | $25.1M | -33.5% |
| Long-term Debt | $22.6M | -5.2% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$44.8M | -97.8% |
| Capital Expenditures | $1.9M | +186.9% |
| Investing Cash Flow | $78.6M | — |
| Financing Cash Flow | -$10.6M | -162.2% |
| Free Cash Flow | -$46.7M | -100.3% |
| $34.7M |
| -57.9% |
| Stockholders' Equity | $27.7M | +159.8% |